Typescript letter, with additions made in ink, written on Lilly Research Laboratories letterhead and signed by G. H. A. Clowes. Includes an autograph postscript regarding the use of the trade name 'Iletin.' The letter discusses the difficulty of standardization and gives details about Lilly insulin lot numbers 708, 329, and 338.